FdaApplication

ANDA 209702

Back to search

Identifiers

Properties

PropertyValue
applicant_nameSOMERSET THERAPEUTICS LLC
application_typeANDA
approval_date2020-02-28

Products (2)

ProductActive ingredientStrengthDosage form
TERIFLUNOMIDETERIFLUNOMIDE7MGTABLET;ORAL
TERIFLUNOMIDETERIFLUNOMIDE14MGTABLET;ORAL

2 products